Uniphar plc (LON:UPR - Get Free Report) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as GBX 348 ($4.65) and last traded at GBX 348 ($4.65), with a volume of 3240 shares changing hands. The stock had previously closed at GBX 344 ($4.60).
Analyst Upgrades and Downgrades
UPR has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a GBX 375 ($5.01) target price on shares of Uniphar in a research report on Wednesday, July 30th. Shore Capital reaffirmed a "buy" rating on shares of Uniphar in a research report on Thursday, May 29th.
Read Our Latest Stock Report on UPR
Uniphar Price Performance
The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.48. The stock has a market cap of £1.06 billion, a price-to-earnings ratio of 23.71 and a beta of 0.75. The stock has a 50-day moving average price of GBX 321.77 and a two-hundred day moving average price of GBX 260.92.
Uniphar Company Profile
(
Get Free Report)
Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Uniphar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Uniphar wasn't on the list.
While Uniphar currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
